Thursday, September 29, 2016

Cedax


Cedax is a brand name of ceftibuten, approved by the FDA in the following formulation(s):


CEDAX (ceftibuten dihydrate - capsule; oral)



  • Manufacturer: PERNIX THERAP

    Approval date: December 20, 1995

    Strength(s): EQ 400MG BASE [RLD]

CEDAX (ceftibuten dihydrate - for suspension; oral)



  • Manufacturer: PERNIX THERAP

    Approval date: December 20, 1995

    Strength(s): EQ 90MG BASE/5ML [RLD]

Has a generic version of Cedax been approved?


No. There is currently no therapeutically equivalent version of Cedax available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cedax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Stable hydrated cephalosporin dry powder for oral suspension formulation
    Patent 5,599,557
    Issued: February 4, 1997
    Inventor(s): Johnson; Donald A. & Wearley; Lorraine & Galeos; Rebecca & Sequeira; Joel A.
    Assignee(s): Schering Corporation
    A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
    Patent expiration dates:

    • April 30, 2013
      ✓ 
      Drug product


    • February 4, 2014
      ✓ 
      Patent use: METHOD OF TREATING BACTERIAL INFECTIONS
      ✓ 
      Drug product


    • February 4, 2014
      ✓ 
      Patent use: TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER.
      ✓ 
      Drug product



See also...

  • Cedax Consumer Information (Wolters Kluwer)
  • Cedax Suspension Consumer Information (Wolters Kluwer)
  • Cedax Consumer Information (Cerner Multum)
  • Cedax Advanced Consumer Information (Micromedex)
  • Cedax AHFS DI Monographs (ASHP)
  • Ceftibuten Consumer Information (Wolters Kluwer)
  • Ceftibuten Suspension Consumer Information (Wolters Kluwer)
  • Ceftibuten Consumer Information (Cerner Multum)
  • Ceftibuten Advanced Consumer Information (Micromedex)
  • Ceftibuten AHFS DI Monographs (ASHP)

No comments:

Post a Comment